Find My Journal

BT

Bee Choo Tai

National University of Singapore SG

0000-0002-4420-7746

305

Publications

6,807

Citations

40

H-Index

108

i10-Index

1.26

2yr Mean Cite

-

Cite/Paper

Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Publications

305 total

Pembrolizumab plus lenvatinib in recurrent gynaecological clear cell carcinoma (LARA): a multicentre, single-arm, phase 2 trial.

N. Ngoi, Jung-yun Lee, Diana Lim, Y.L. Thian, Yi Wan Lim - The Lancet Oncology, 2026

Cited by 2 Semantic Scholar

1086eP An observational study of afatinib 30mg daily in patients with advanced non-small cell lung cancer (NSCLC) harbouring common EGFR mutations

K. Sooi, P. Danchaivijitr, V.T. Dao, C. Wong, M. Sachdeva - Annals of Oncology, 2025

Cited by 0 Semantic Scholar

Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trial.

W. Chong, J. Low, J.K. Tay, T. Le, Grace Shi-Qing Goh - The Lancet Oncology, 2025

Cited by 15 Semantic Scholar

848MO Phase II open-label randomized study of pembrolizumab with or without bevacizumab in platinum-resistant recurrent/metastatic nasopharyngeal carcinoma (R/M NPC)

W. Chong, J. Low, K. Sooi, R.A. Soo, C. Le - Annals of Oncology, 2024

Cited by 1 Semantic Scholar

753P Unlocking the circulating immune landscape of advanced clear-cell ovarian cancer: Insights from the MOCCA trial

F. Blanc-Durand, N. Ngoi, N. Kaliaperumal, V. Bijin Au, Norlelawati Binti Talib - Annals of Oncology, 2024

Cited by 1 Semantic Scholar

788P Pembrolizumab plus lenvatinib (PL) in recurrent clear cell gynecological cancer (CCGC): Phase II LARA trial (GCGS-OV4/ APGOT-OV3)

N. Ngoi, J-Y. Lee, D. Lim, Y.L. Thian, Y.W. Lim - Annals of Oncology, 2024

Cited by 7 Semantic Scholar

73MO Longitudinal probing of combinatorial immunotherapy (anti-VEGF/anti-PD1) response in advanced nasopharyngeal carcinoma, at single cell resolution

S. Chia, N. Shirgaonkar, Y.C. Lim, J.K. Tay, W. Chong - Annals of Oncology, 2024

Cited by 0 Semantic Scholar

LBA8 Preliminary efficacy of pembrolizumab plus lenvatinib (PL) in recurrent clear cell gynecological cancer (CCGC): Phase II LARA trial (GCGS-OV4/ APGOT-OV3)

N. Ngoi, J. Lee, Y.W. Lim, D. Lim, Y.L. Thian - Annals of Oncology, 2023

Cited by 2 Semantic Scholar

Injectable Cultured Bone Marrow–Derived Mesenchymal Stem Cells in Varus Knees With Cartilage Defects Undergoing High Tibial Osteotomy: A Prospective, Randomized Controlled Clinical Trial With 2 Years' Follow‐up

Keng Lin Wong, Kevin Boon Leng Lee, Bee Choo Tai, Ping‐Yee Law, Eng Hin Lee et al. - Arthroscopy The Journal of Arthroscopic and Related Surgery, 2013

Cited by 386 OpenAlex

Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis PDF

Wen Cai Zhang, Ng Shyh‐Chang, Yang He, Amit Rai, Shivshankar Umashankar et al. - Cell, 2012

Cited by 672 OpenAlex

Research Topics

Ovarian cancer diagnosis and treatment (33) Mobile Health and mHealth Applications (16) Head and Neck Cancer Studies (14) Organ Donation and Transplantation (13) Adolescent Sexual and Reproductive Health (12)

Affiliations

University of California, Los Angeles

US 2020 - 2020

National University of Singapore

SG 2026 - 2004

Nanyang Technological University

SG 2007 - 2007

Singapore General Hospital

SG 2019 - 2007

Singapore College of Traditional Chinese Medicine

SG 2019 - 2009

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers